ArticleBMC gastroenterology2024
Evaluation of soluble suppression of tumorigenicity 2 (sST2) as serum marker for liver fibrosis.
Florian F Hildenbrand et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it